 THE WOODLANDS, Texas, June 25, 2021 GLOBE NEWSWIRE -- Lexicon Pharmaceuticals, Inc. Nasdaq: LXRX, announced today there will be a symposium highlighting sotagliflozin followed by a live video question and answer period during the American Diabetes Associations 81st Scientific Sessions being held virtually June 25, 2021 through June 29, 2021: 